Shares soar for company as FDA approves application for trial of weed-derived coronavirus drug
Shares for a cannabis company spiked 324% after the FDA said it could apply to run a clinical trial of its marijuana-derived drug to treat coronavirus patients FSD Pharma received approval from the FDA to apply to run a clinical trial of a cannabis-derived drug on coronavirus patients The drug mimics molecules naturally found in marijuana … Read more